Results 151 to 160 of about 25,793 (226)

Spatiotemporal dynamics of <i>Bacillus anthracis</i> under climate change: a machine learning approach. [PDF]

Front Microbiol
Khalaf SMH, Alqahtani MSM, Selim YA, Elsayed KO, Bendary HA.   +4 more
europepmc   +1 more source

Stanley Plotkin, MD, Discusses Scientific Progress and the Complexities of Public Health Vaccine Policy. [PDF]

Pathog Immun
Greenspan NS, Lederman MM.
europepmc   +1 more source

Bispecific antibody engineered from two non-protective antibodies confers full protection against anthrax toxin through inhibition of PA83 cleavage. [PDF]

Microbiol Spectr
Chen Z, Zhang G, Han J, Zhu Z, Wang M, Fang T, Li Z, Dong Y, Li J, Yu C, Chi X.   +10 more
europepmc   +1 more source

Genomic adaptability and virulence of Bacillus anthracis: a machine learning-based pan-genome and comparative analysis. [PDF]

BMC Genomics
Sekar YS, Chellapandi P, Suresh KP, Saranya SV, Papanna M, Gulati BR, Amachawadi RG, Khatoon M, Hemadri D, Archana CA, Rani S, Patil A, Palavesam A, Sagar N, Anand J, Patil SS.   +15 more
europepmc   +1 more source

The Anthrax Toxin Lethal Factor in Solution Does Not Have the Protein's Crystallized Structure. [PDF]

Toxins (Basel)
Rubinson KA, Kasianowicz JJ.
europepmc   +1 more source

Case report: Clinical characteristics of anthrax meningoencephalitis: two cases diagnosed using metagenomic next-generation sequencing and literature review. [PDF]

Front Med (Lausanne)
Hu M, Qiao X, Zhang J, Qin D, Guo S, Zhao W, Wang C.   +6 more
europepmc   +1 more source

The application of multiplex PCR and PCR-restriction fragment length polymorphism for differentiation of <i>Bacillus anthracis</i> from other <i>Bacillus</i> spp. [PDF]

J Vet Res
Kędrak-Jabłońska A, Budniak S.
europepmc   +1 more source

[The capacity of the causative agent of anthrax to reduce methylene blue].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 2000
S A, Eremin, A K, Nikiforov, T A, Kostiukova, N I, Mikshis   +3 more
openaire   +1 more source

Highly Sensitive Field Detection Technology for Anthrax Based on the CRISPR/Cas13a System. [PDF]

Microb Biotechnol
Fan J, Huang L, Chen J, Jiang Y, Du X, Wang L, Ding K, Huang J, Qiu S, Liu H, Song H.   +10 more
europepmc   +1 more source

From pandemics to preparedness: harnessing AI, CRISPR, and synthetic biology to counter biosecurity threats. [PDF]

Front Public Health
Okon MB, Ugwu OP, Ugwu CN, Ogenyi FC, Swase DT, Anyanwu CN, Eze VHU, Ugwu JN, Akinola SA, Mujinya R, Anyanwu EG.   +10 more
europepmc   +1 more source